Crispr Therapeutics shares owned by Stempoint Capital
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Stempoint Capital
from 13F filings
Historical chart of Stempoint Capital investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Stempoint Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Stempoint Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $59k | 40k | 1.48 |